CSCI
COSCIENS Biopharma Inc.
NASDAQ · Healthcare · Biotechnology · CA
$2.72
+0.00%Leverage
- Debt / equity
- 0.32x
- Net debt / equity
- -1.00x
- Debt / assets
- 0.08x
- Debt / EBITDA
- -0.14x
- Net debt / EBITDA
- 0.44x
Liquidity & coverage
- Current ratio
- 2.98x
- Quick ratio
- 2.65x
- Cash ratio
- 1.69x
- Interest coverage
- -136.07x
- EBITDA / interest
- -118.42x
- Working capital
- $11.0M
Cash & dividend
- FCF / debt
- -8.06x
- Cash flow / debt
- -7.57x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2025